Colonics
 
About Me

Colonics resources

Recent Posts
Menu
Calendar
«  December 2014  »
MonTueWedThuFriSatSun
1234567
891011121314
15161718192021
22232425262728
293031 

Friends
    Links


    Entry 1 of 3211
    Last Page | Next Page
    10/25/2010 - Intercell's IC43 Phase II trial against Pseudomonas aeruginosa infections meets primary endpoint
    Posted in Medical News

    Intercell AG today announced results from a Phase II clinical trial involving the company's investigational nosocomial vaccine petitioner (IC43) against infections with the bacillus Pseudomonas aeruginosa, a leading cause of hospital-acquired infections with increasing antibiotic oppugnation and hence a very high unmet medical need.

    More: - The rest...

    Share |

    :: Send to a Friend!

    Share and enjoy
    • Digg
    • del.icio.us
    • DZone
    • Netvouz
    • NewsVine
    • Reddit
    • Slashdot
    • StumbleUpon
    • Technorati
    • YahooMyWeb
     
    portfolio